A detailed history of Simplex Trading, LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Simplex Trading, LLC holds 6,151 shares of LEGN stock, worth $312,470. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,151
Holding current value
$312,470
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$39.5 - $57.22 $242,964 - $351,960
6,151 New
6,151 $272,000
Q4 2023

Feb 02, 2024

BUY
$57.25 - $69.74 $40,304 - $49,096
704 New
704 $42,000
Q2 2022

Aug 03, 2022

SELL
$33.54 - $55.0 $56,380 - $92,455
-1,681 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$31.02 - $48.18 $9,988 - $15,513
-322 Reduced 16.08%
1,681 $61,000
Q2 2021

Aug 12, 2021

BUY
$25.8 - $41.09 $51,187 - $81,522
1,984 Added 10442.11%
2,003 $82,000
Q1 2021

Apr 26, 2021

BUY
$23.55 - $32.4 $447 - $615
19 New
19 $0

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $8.5B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.